retatrutide triple agonist gip glp-1 glucagon receptor vs. Tirzepatide: The Next-Gen Showdown retatrutide triple agonist glp-1 gip

[Abstract]2026 Apr 14

Abstract Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with limited treatment options, where neuroinflammation and gut microbiota dysbiosis are emerging as interconnected therapeutic targets

Biohacker Protocol (experimental) Dose: 300 mcg (1 capsule) Duration: 8 12 weeks Frequency: 1 capsule daily, continuous low-dose exposure Cycle Interval: 4 weeks off after each cycle Goal / Description: Explored for sustained mitochondrial biogenesis and metabolic adaptation in long-term models

Voltage sag can affect device performance significantly

If your protocol uses higher doses (100200mcg), a 1mL reconstitution (1000mcg/mL) reduces injection volume and allows more total doses from a single vial